Cargando…

The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study

Detalles Bibliográficos
Autores principales:	Carrión, Ricardo E., Auther, Andrea M., McLaughlin, Danielle, Cornblatt, Barbara A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452606/ https://www.ncbi.nlm.nih.gov/pubmed/34364033 http://dx.doi.org/10.1016/j.schres.2021.07.006

Ejemplares similares

Treating early psychosis: who, what, and when?
por: Cornblatt, Barbara A., et al.
Publicado: (2005)

DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2020)

“Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate
por: Shrivastava, Amresh, et al.
Publicado: (2011)

F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER
por: Foss-Feig, Jennifer, et al.
Publicado: (2018)

Attenuated positive and negative symptoms in patients at clinical high-risk for psychosis
por: Omelchenko, M.
Publicado: (2022)

"Attenuated Psychosis Syndrome" or "Subthreshold Prodromal State"?
por: Kontaxakis, Vassilis, et al.
Publicado: (2013)

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis
por: Davies, Cathy, et al.
Publicado: (2018)

Correlations of thought disorders with attenuated positive symptoms at clinical high-risk state for psychosis
por: Kaleda, V., et al.
Publicado: (2023)

Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study
por: Foss-Feig, Jennifer H., et al.
Publicado: (2021)

T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Worthington, Michelle, et al.
Publicado: (2020)

Psychosis and pandemics: Is there a secret protector?
por: Vukojević, Jakša, et al.
Publicado: (2020)

Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status
por: Tran, Tanya, et al.
Publicado: (2023)

Calloso-frontal tuberculoma presenting with symptoms of psychosis and catatonia
por: Das, Sourav, et al.
Publicado: (2015)

The role of cognitive control in the positive symptoms of psychosis
por: Horne, Charlotte M., et al.
Publicado: (2022)

Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis
por: Deng, Wisteria, et al.
Publicado: (2021)

Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial
por: McFarlane, William R., et al.
Publicado: (2015)

Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition
por: Staines, Lorna, et al.
Publicado: (2021)

Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis
por: Bernard, Jessica A., et al.
Publicado: (2017)

Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study
por: Edwards, J., et al.
Publicado: (2011)

Persistent negative symptoms in individuals at Ultra High Risk for psychosis
por: Yung, Alison R., et al.
Publicado: (2019)

Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes
por: Deng, Wisteria, et al.
Publicado: (2023)

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis
por: Devoe, Daniel J., et al.
Publicado: (2023)

Attenuated Psychosis Syndrome
por: Reddy, M. S.
Publicado: (2014)

Factor Structure of the Clinician-Rated Dimensions of Psychosis Symptom Severity in Patients with Schizophrenia
por: Park, Seon-Cheol, et al.
Publicado: (2016)

Emotional Experiences Predict the Conversion of Individuals with Attenuated Psychosis Syndrome to Psychosis: A 6-Month Follow up Study
por: Chen, Fa Zhan, et al.
Publicado: (2016)

The Activity Coefficient of Sodium in Striated Muscle Fibers
por: McLaughlin, S.
Publicado: (1968)

Psychopathological consequences of the COVID-19 pandemic: A case report of psychosis
por: Seiler, Natalie, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia
por: Strauss, Gregory P., et al.
Publicado: (2021)

Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis
por: Hermans, Karlijn S. F. M., et al.
Publicado: (2021)

Abnormal hippocampal–thalamic white matter tract development and positive symptom course in individuals at ultra-high risk for psychosis
por: Bernard, Jessica A, et al.
Publicado: (2015)

Cross-country comparison of media reporting of celebrity suicide in the immediate week: A pilot study
por: Menon, Vikas, et al.
Publicado: (2020)

Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort
por: Cullen, Alexis E., et al.
Publicado: (2020)

Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis
por: Collins, Meghan A., et al.
Publicado: (2021)

The COVID-19 Pandemic Introduces Diagnostic and Treatment Planning Complexity for Individuals at Clinical High Risk for Psychosis
por: Mittal, Vijay A, et al.
Publicado: (2021)

Statin-Induced Immune-Mediated Necrotizing Myopathy Does Not Always Present With Immediate or Severe Symptoms
por: Kang, Minsung, et al.
Publicado: (2022)

O9.8. STRESS AND COGNITIVE FUNCTION AMONG INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS: FINDINGS FROM THE NAPLS COHORT
por: Cullen, Alexis, et al.
Publicado: (2018)

Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis: A Systematic Review and Meta-analysis
por: Penney, Danielle, et al.
Publicado: (2022)

Cognitive-Behavioral Social Skills Training: Outcome of a Randomized Controlled Trial for Youth at Risk of Psychosis
por: Addington, Jean, et al.
Publicado: (2023)

Attenuated niacin-induced skin flush response in individuals with clinical high risk for psychosis
por: Gan, Ranpiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vja6ond2ju0q3cab8brmualefi